Wall Street Says Ginkgo Bioworks Stock Will Soar 132%, and Cathie Wood's Buying It. Should You?The Motley Fool • 10/04/23
3 Stocks Wall Street Thinks Can Nearly Double -- and Why They Might Be Dead WrongThe Motley Fool • 10/04/23
Nosh.bio Leverages Ginkgo Strain Optimization Services to Enhance Meaty Taste of MycoproteinPRNewsWire • 10/02/23
Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease SpilloverPRNewsWire • 09/29/23
Ensovi Leverages Ginkgo Enzyme Services to Optimize Cell-Free Carbon Fixation Process for BiomanufacturingPRNewsWire • 09/28/23
2 Beaten-Down Growth Stocks That Could Rocket 107% to 127% Higher, According to Wall StreetThe Motley Fool • 09/26/23
Ginkgo Bioworks and the Government of the Republic of Madagascar Announce Plans to Develop New Biosecurity CapabilitiesPRNewsWire • 09/25/23
These 2 Growth Stocks Are Down More Than 20%, but Billionaires Are Buying Them Hand Over FistThe Motley Fool • 09/23/23
Ginkgo Bioworks is Teaming Up With Alphabet For AI, But Does That Make It a Buy?The Motley Fool • 09/20/23
Factorial Biotechnologies and Ginkgo Bioworks Partner To Develop Enzyme for Single-Cell Library Prep TechnologyPRNewsWire • 09/18/23
Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the WorldPRNewsWire • 09/12/23
Cathie Wood Is Buying These 2 Biotech Stocks Hand Over Fist, and Wall Street Thinks They Could DoubleThe Motley Fool • 09/10/23
Ginkgo Bioworks Announces Participation in Morgan Stanley 21st Annual Global Healthcare ConferencePRNewsWire • 09/06/23
Exacta Bioscience and Ginkgo Bioworks Announce Partnership to Optimize Exacta's Crop Protection ProductPRNewsWire • 08/31/23